Aim and Scope

Defining the scientific and clinical focus of neurological research and therapy.

JNRT advances neurological science by publishing research that improves diagnosis, treatment, and rehabilitation for disorders of the nervous system. We prioritize studies that deliver clinical relevance, methodological rigor, and translational value.

Our goal is to accelerate evidence based care and ensure neurological discoveries translate into meaningful patient outcomes. Manuscripts should clearly connect findings to neurological practice or therapeutic decision making.

JNRT covers clinical neurology, basic neuroscience, translational therapeutics, and neurorehabilitation. Manuscripts should demonstrate clear neurological relevance and describe measurable outcomes.

Interdisciplinary research is welcome when the primary contribution remains anchored in neurology or neuroscience. We also encourage work that bridges diagnostics, therapeutics, and long term care pathways.

• Stroke, cerebrovascular disease, and neurocritical care
• Epilepsy, seizure disorders, and neurophysiology
• Movement disorders and neurodegenerative disease
• Neuroimmunology, multiple sclerosis, and inflammation
• Neuroimaging, biomarkers, and diagnostic advances
• Neurorehabilitation, functional recovery, and outcomes
• Neuro-oncology and neurogenetics
• Pediatric neurology and developmental disorders

JNRT welcomes imaging and diagnostic research that improves neurological decision making. Studies should describe imaging protocols, validation cohorts, and diagnostic performance metrics.

Submissions that link imaging biomarkers to clinical outcomes are especially relevant.

Rehabilitation research is central to neurological outcomes. Manuscripts should report functional recovery, cognitive outcomes, and long term care pathways.

We welcome studies that evaluate rehabilitation programs, assistive technologies, and care transitions.

Implementation research that tests neurological interventions in real world settings is encouraged. Studies should describe scalability, cost effectiveness, and system integration.

Evidence that improves access to neurological care or reduces disparities aligns with the JNRT scope.

• Randomized clinical trials and pragmatic studies
• Prospective or retrospective cohort studies
• Systematic reviews and meta analyses
• Translational and preclinical studies with clinical relevance
• Case series with clear methodology and follow up

JNRT emphasizes evidence that informs patient care, including diagnostics, therapeutic strategies, and rehabilitation programs. Studies should explain clinical implications and provide measurable outcomes.

Translational work is encouraged when preclinical findings demonstrate a clear pathway to clinical application.

We welcome studies on pharmacologic, device, and behavioral interventions that address neurological disorders. Clinical trials should include registration identifiers and clear reporting of endpoints.

Comparative effectiveness studies and real world evaluations are valued when they inform clinical decision making.

JNRT publishes neuroimaging and biomarker research that advances diagnosis, prognosis, or treatment monitoring. Methods should be reproducible and validated in clinically relevant populations.

Submissions should report imaging protocols, statistical thresholds, and diagnostic performance metrics.

JNRT expects transparent methods, defined outcomes, and appropriate statistical reporting. Data availability statements and repository links should be provided when possible.

Clear reporting strengthens reproducibility and supports evidence based neurological care.

• Report adverse events and safety profiles when applicable
• Define clinical endpoints and follow up duration
• Include patient reported outcomes when relevant
• Describe functional or quality of life impact

• Neurological relevance is clear in title and abstract
• Methods and outcomes are aligned with study aims
• Data availability statement is included
• Ethics approvals and consent are documented
• Clinical implications are explained in discussion

• CONSORT for randomized trials
• STROBE for observational studies
• PRISMA for systematic reviews
• CARE for case reports

Manuscripts focused solely on non-neurological conditions, or basic biology without a clear neurological contribution, fall out of scope. Studies must demonstrate relevance to neurological outcomes or mechanisms.